AbCellera Share Price

AbCellera Share Price

NASDAQ: ABCL | Mid Cap | Healthcare
$10.47
-$0.54 (-4.95%) Last updated on 20 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

AbCellera Stock Performance

Open
$11.19
Prev. Close
$11.02
Circuit Range
N/A
Day Range
$10.39 - $11.26
Year Range
$2.75 - $15.02
Volume
1,03,030
Average Traded
$10.71

AbCellera Share Price Today

As of 20 November 2026, AbCellera Biologics Inc.'s share price is $10.47. The stock opened at $11.19, compared to its previous close of $11.02. During today's trading session, AbCellera Biologics Inc.'s share price traded between $10.39 and $11.26, with an average price of $10.82. Over the past 52 weeks, the stock has recorded a high of $15.02 and a low of $2.75. In terms of performance, AbCellera Biologics Inc.'s share price has risen by 69.42% over the last six months and is up 179.95% on a year-on-year basis.

AbCellera Share Price Chart

Line chart of the AbCellera price trend over the selected period. The price fell overall, ranging from 10.96 to 11.54, ending at 11.03.
$10.39$11.26
L
Show Current Price
H

AbCellera Stock Fundamentals & Key Indicators

Market Cap
$3.13B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.45
Revenue (TTM)
$75.13B
Return On Equity (TTM)
-13.96%
Profit Margin
-194.88%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-355.42%

AbCellera Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$44.85$8.32$4.05$10.64
Net Profit-$8.95-$43.17-$55.43-$40.76
Net Profit Margin-19.96%-518.87%-1368.64%-383.08%
Income ChangeN/A-382.35%-28.40%26.47%

AbCellera Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$485.42$38.03$28.83$75.13
Net Profit$158.52-$146.40-$162.86-$146.41
Net Profit Margin32.66%-384.96%-564.90%-194.88%
Income ChangeN/A-192.35%-11.24%10.10%

AbCellera Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets628.72609.18616.11515.42
Current Assets728.23751.37871.991025.49
Total Assets1356.951360.551488.091540.91
Non Current Liabilities325.74227.86216.76189.31
Current Liabilities64.3176.61119.01118.32
Total Liabilities390.05304.47335.78307.63
Shareholders' Equity966.91056.081152.321233.28

AbCellera Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-131.3-108.56-43.88277.36
Investing87.75121.41-221.11-352.63
Financing14.0812.7710.36-1.63

About AbCellera

AbCellera Biologics Inc is a clinical-stage biotechnology company focused on discovering and developing first-in-class antibody medicines for indications with high unmet medical need. It has built a platform for advancing antibody drug programs that the company believes provides it with a competitive advantage in addressing challenging, high-value targets such as complex transmembrane proteins and novel modalities, including multispecifics and antibody-drug conjugates. Organisation's pipeline includes two drug candidates in clinical development, two development candidates in Investigational New Drug (IND/Clinical Trial Application (CTA)-enabling activities, and more than 20 active discovery programs across multiple modalities and indications.

AbCellera Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$12.33
$10.44
-14.67%
Oct 2026
$14.57
$12.23
-16.23%
Sep 2026
$11.28
$14.61
+17.92%
Aug 2026
$5.68
$12.38
+116.90%
Jul 2026
$7.78
$5.71
-27.17%
Jun 2026
$6.13
$7.84
+26.86%
May 2026
$4.13
$6.18
+48.74%
Apr 2026
$3.53
$4.16
+18.88%
Mar 2026
$3.48
$3.50
-2.92%
Feb 2026
$3.56
$3.60
-0.55%
Jan 2026
$3.46
$3.62
+6.16%
Dec 2025
$3.58
$3.41
-8.82%

AbCellera Share Price FAQs